CN Stock MarketDetailed Quotes

300003 Lepu Medical Technology

Watchlist
  • 12.59
  • +0.01+0.08%
Market Closed Nov 6 15:00 CST
23.68BMarket Cap33.48P/E (TTM)

About Lepu Medical Technology Company

The company was founded in 1999 and is one of the earliest enterprises engaged in the development and manufacture of interventional cardiac devices in China. The company has always focused on providing a full range of services for cardiovascular patients, driving high-quality development through innovation, and has now become a leading domestic cardiovascular health industry platform. As an overall solution provider for the entire life cycle in the field of cardiovascular diseases, the company's business segments are divided into medical devices, pharmaceuticals, medical services and health management. The company's main products include cardiovascular implantation, in vitro diagnosis, surgical anesthesia, APIs and preparations, medical services and health management.

Company Profile

Short Name-A乐普医疗
Symbol-A300003
Company NameLepu Medical Technology (Beijing) Co., Ltd.
Listing DateOct 30, 2009
Issue Price29.00
Shares Offered41.00M share(s)
FoundedJun 11, 1999
Legal Representativezhongjie pu
General Managerfei pu
Secretaryweina jiang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Legal CounselBeijing Zhong Lun Law Firm
Employees2098
Phone010-80120622
Office AddressNo. 37 Chaoqian Road, Changping District, Beijing
Zip Code102200
Registered AddressNo. 37 Chaoqian Road, Changping District, Beijing
Fax010-80120776
Emailzqb@lepumedical.com
Business License110000410140103
BusinessProduction and sale of medical devices and their accessories; technical development of medical devices and accessories; provision of technical consulting services for self-produced products; import and export of the above products; technology import and export; commission agents (excluding auctions, products involving quota license management, and special regulations are handled in accordance with relevant national regulations). (Market players independently choose business projects and carry out business activities according to law; for projects subject to approval according to law, they carry out business activities according to the approved content after approval by the relevant departments; they are not allowed to engage in business activities prohibited or restricted by national and municipal industrial policies.)

Company Executives

  • Name
  • Position
  • Salary
  • zhongjie pu
  • Chairman, Directors, Technical Director, Nomination Committee Members, Chairman of the Strategy Committee
  • --
  • qihong wang
  • Vice Chairman, Directors, Nomination Committee Members, Strategy Committee Member, Member of the Remuneration and Assessment Committee
  • --
  • yang xu
  • Directors, Member of the Remuneration and Assessment Committee
  • 300.00K
  • fei pu
  • Directors, General Manager, Audit Committee Member
  • 874.10K
  • xin qu
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • 300.00K
  • lihua wang
  • Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
  • 300.00K
  • liang gan
  • Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee
  • 300.00K
  • weina jiang
  • Board Secretary
  • 1.44M
  • xinglin wang
  • Chairman of the Supervisory Board, Auditors
  • 800.00K
  • jun wang
  • Auditors
  • --
  • xiaoying feng
  • Deputy General Manager
  • 1.25M
  • bingfeng zhang
  • Deputy General Manager
  • 1.53M
  • yong wang
  • Senior Deputy General Manager, Chief Financial Officer
  • 1.70M
  • zhanjiang wei
  • Senior Deputy General Manager
  • 1.70M
  • qian chen
  • Employee Supervisors
  • 460.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data